Global and United States Noninvasive Prenatal Testing Service Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 Noninvasive Prenatal Testing Service Revenue in Noninvasive Prenatal Testing Service Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Noninvasive Prenatal Testing Service Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Noninvasive Prenatal Testing Service Market Size for the Year 2017-2028
  • 1.2.2 Global Noninvasive Prenatal Testing Service Market Size for the Year 2017-2028
• 1.3 Noninvasive Prenatal Testing Service Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.3.1 The Market Share of United States Noninvasive Prenatal Testing Service in Global, 2017 VS 2022 VS 2028
  • 1.3.2 The Growth Rate of Noninvasive Prenatal Testing Service Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.4 Noninvasive Prenatal Testing Service Market Dynamics
  • 1.4.1 Noninvasive Prenatal Testing Service Industry Trends
  • 1.4.2 Noninvasive Prenatal Testing Service Market Drivers
  • 1.4.3 Noninvasive Prenatal Testing Service Market Challenges
  • 1.4.4 Noninvasive Prenatal Testing Service Market Restraints
• 1.5 Study Objectives
• 1.6 Years Considered

2 Noninvasive Prenatal Testing Service by Type

• 2.1 Noninvasive Prenatal Testing Service Market Segment by Type
  • 2.1.1 NIPT
  • 2.1.2 NIPT Plus
• 2.2 Global Noninvasive Prenatal Testing Service Market Size by Type (2017, 2022 & 2028)
• 2.3 Global Noninvasive Prenatal Testing Service Market Size by Type (2017-2028)
• 2.4 United States Noninvasive Prenatal Testing Service Market Size by Type (2017, 2022 & 2028)
• 2.5 United States Noninvasive Prenatal Testing Service Market Size by Type (2017-2028)

3 Noninvasive Prenatal Testing Service by Application

• 3.1 Noninvasive Prenatal Testing Service Market Segment by Application
  • 3.1.1 Chromosomal Abnormalities
  • 3.1.2 Assisted Reproduction
  • 3.1.3 Others
• 3.2 Global Noninvasive Prenatal Testing Service Market Size by Application (2017, 2022 & 2028)
• 3.3 Global Noninvasive Prenatal Testing Service Market Size by Application (2017-2028)
• 3.4 United States Noninvasive Prenatal Testing Service Market Size by Application (2017, 2022 & 2028)
• 3.5 United States Noninvasive Prenatal Testing Service Market Size by Application (2017-2028)

4 Global Noninvasive Prenatal Testing Service Competitor Landscape by Company

• 4.1 Global Noninvasive Prenatal Testing Service Market Size by Company
  • 4.1.1 Top Global Noninvasive Prenatal Testing Service Companies Ranked by Revenue (2021)
  • 4.1.2 Global Noninvasive Prenatal Testing Service Revenue by Player (2017-2022)
• 4.2 Global Noninvasive Prenatal Testing Service Concentration Ratio (CR)
  • 4.2.1 Noninvasive Prenatal Testing Service Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Companies of Noninvasive Prenatal Testing Service in 2021
  • 4.2.3 Global Noninvasive Prenatal Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Noninvasive Prenatal Testing Service Headquarters, Revenue in Noninvasive Prenatal Testing Service Business (2017-2022) & (US$ Million) Type
  • 4.3.1 Global Noninvasive Prenatal Testing Service Headquarters and Area Served
  • 4.3.2 Global Noninvasive Prenatal Testing Service Companies Revenue in Noninvasive Prenatal Testing Service Business (2017-2022) & (US$ Million) Type
  • 4.3.3 Date of International Companies Enter into Noninvasive Prenatal Testing Service Market
• 4.4 Companies Mergers & Acquisitions, Expansion Plans
• 4.5 United States Noninvasive Prenatal Testing Service Market Size by Company
  • 4.5.1 Top Noninvasive Prenatal Testing Service Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Noninvasive Prenatal Testing Service Revenue by Players (2020, 2021 & 2022)

5 Global Noninvasive Prenatal Testing Service Market Size by Region

• 5.1 Global Noninvasive Prenatal Testing Service Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Noninvasive Prenatal Testing Service Market Size by Region (2017-2028)
  • 5.2.1 Global Noninvasive Prenatal Testing Service Market Size by Region: 2017-2022
  • 5.2.2 Global Noninvasive Prenatal Testing Service Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Noninvasive Prenatal Testing Service Market Size YoY Growth 2017-2028
  • 6.1.2 North America Noninvasive Prenatal Testing Service Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Noninvasive Prenatal Testing Service Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Noninvasive Prenatal Testing Service Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Noninvasive Prenatal Testing Service Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Noninvasive Prenatal Testing Service Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Noninvasive Prenatal Testing Service Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Noninvasive Prenatal Testing Service Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Noninvasive Prenatal Testing Service Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Noninvasive Prenatal Testing Service Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 Illumina
  • 7.1.1 Illumina Company Details
  • 7.1.2 Illumina Business Overview
  • 7.1.3 Illumina Noninvasive Prenatal Testing Service Introduction
  • 7.1.4 Illumina Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.1.5 Illumina Recent Development
• 7.2 Natera
  • 7.2.1 Natera Company Details
  • 7.2.2 Natera Business Overview
  • 7.2.3 Natera Noninvasive Prenatal Testing Service Introduction
  • 7.2.4 Natera Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.2.5 Natera Recent Development
• 7.3 LifeLabs
  • 7.3.1 LifeLabs Company Details
  • 7.3.2 LifeLabs Business Overview
  • 7.3.3 LifeLabs Noninvasive Prenatal Testing Service Introduction
  • 7.3.4 LifeLabs Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.3.5 LifeLabs Recent Development
• 7.4 NiftyTest
  • 7.4.1 NiftyTest Company Details
  • 7.4.2 NiftyTest Business Overview
  • 7.4.3 NiftyTest Noninvasive Prenatal Testing Service Introduction
  • 7.4.4 NiftyTest Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.4.5 NiftyTest Recent Development
• 7.5 Labcorp
  • 7.5.1 Labcorp Company Details
  • 7.5.2 Labcorp Business Overview
  • 7.5.3 Labcorp Noninvasive Prenatal Testing Service Introduction
  • 7.5.4 Labcorp Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.5.5 Labcorp Recent Development
• 7.6 Xcelom
  • 7.6.1 Xcelom Company Details
  • 7.6.2 Xcelom Business Overview
  • 7.6.3 Xcelom Noninvasive Prenatal Testing Service Introduction
  • 7.6.4 Xcelom Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.6.5 Xcelom Recent Development
• 7.7 Veritas
  • 7.7.1 Veritas Company Details
  • 7.7.2 Veritas Business Overview
  • 7.7.3 Veritas Noninvasive Prenatal Testing Service Introduction
  • 7.7.4 Veritas Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.7.5 Veritas Recent Development
• 7.8 Sema4
  • 7.8.1 Sema4 Company Details
  • 7.8.2 Sema4 Business Overview
  • 7.8.3 Sema4 Noninvasive Prenatal Testing Service Introduction
  • 7.8.4 Sema4 Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.8.5 Sema4 Recent Development
• 7.9 CeGaT
  • 7.9.1 CeGaT Company Details
  • 7.9.2 CeGaT Business Overview
  • 7.9.3 CeGaT Noninvasive Prenatal Testing Service Introduction
  • 7.9.4 CeGaT Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.9.5 CeGaT Recent Development
• 7.10 BGI
  • 7.10.1 BGI Company Details
  • 7.10.2 BGI Business Overview
  • 7.10.3 BGI Noninvasive Prenatal Testing Service Introduction
  • 7.10.4 BGI Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.10.5 BGI Recent Development
• 7.11 Berry Genomics
  • 7.11.1 Berry Genomics Company Details
  • 7.11.2 Berry Genomics Business Overview
  • 7.11.3 Berry Genomics Noninvasive Prenatal Testing Service Introduction
  • 7.11.4 Berry Genomics Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.11.5 Berry Genomics Recent Development
• 7.12 Daan Gene
  • 7.12.1 Daan Gene Company Details
  • 7.12.2 Daan Gene Business Overview
  • 7.12.3 Daan Gene Noninvasive Prenatal Testing Service Introduction
  • 7.12.4 Daan Gene Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.12.5 Daan Gene Recent Development
• 7.13 CapitalBio
  • 7.13.1 CapitalBio Company Details
  • 7.13.2 CapitalBio Business Overview
  • 7.13.3 CapitalBio Noninvasive Prenatal Testing Service Introduction
  • 7.13.4 CapitalBio Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.13.5 CapitalBio Recent Development
• 7.14 Annoroad
  • 7.14.1 Annoroad Company Details
  • 7.14.2 Annoroad Business Overview
  • 7.14.3 Annoroad Noninvasive Prenatal Testing Service Introduction
  • 7.14.4 Annoroad Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.14.5 Annoroad Recent Development
• 7.15 Adicon
  • 7.15.1 Adicon Company Details
  • 7.15.2 Adicon Business Overview
  • 7.15.3 Adicon Noninvasive Prenatal Testing Service Introduction
  • 7.15.4 Adicon Revenue in Noninvasive Prenatal Testing Service Business (2017-2022)
  • 7.15.5 Adicon Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
  • 9.1.1 Methodology/Research Approach
  • 9.1.2 Data Source
• 9.2 Author Details